BeOne Medicines Ltd. – Material Contracts Watch

from 10-Q 9 pages Global Restricted Share Unit Award Agreement for Non-Employee Directors Under BeOne Medicines Ltd. 2016 Share Option and Incentive Plan

from 10-Q 3 pages BeOne Medicines Ltd. Independent Non-Executive Director Compensation Policy

from 10-K 264 pages Dated 14 November 2025 BeOne Medicines AG as Company Arranged by the Hongkong and Shanghai Banking Corporation Limited as Global Coordinator the Hongkong and Shanghai Banking Corporation Limited as Original Mandated Lead Arranger and Bookrunner China Merchants Bank Guangzhou Branch (招商银行股份有限公司广州分行), Industrial Bank Co., Ltd Shanghai Branch (A Joint Stock Company Incorporated in P.R.C. With Limited Liability), China Citic Bank Suzhou Branch (Incorporated in China With Limited Liability), China Minsheng Banking Corp., Ltd. Shanghai Pilot Free Trade Zone Branch, Bank of America Europe Designated Activity Company (Incorporated in Ireland Limited by Shares), Bnp Paribas, Banco Bilbao Vizcaya Argentaria, S.A., Niederlassung Deutschland, Dbs Bank (Hong Kong) Limited (Incorporated in Hong Kong With Limited Liability), Morgan Stanley Senior Funding, Inc., Truist Bank, U.S. Bank National Association and Shanghai Pudong Development Bank Co., Ltd. Huangpu Sub-Branch as Mandated Lead Arrangers and Bookrunners Citicorp North America, Inc., Goldman Sachs Bank USA, Hang Seng Bank Limited, Jpmorgan Chase Bank, N.A., Luso International Banking Limited, Mashreqbank Psc, Hong Kong Branch (Incorporated in Dubai U.A.E. With Limited Members Liability), Natixis, Hong Kong Branch (Incorporated in France and the Liability of Its Members Is Limited) and Ubs Switzerland AG as Mandated Lead Arrangers China Citic Bank International Limited (Incorporated in Hong Kong With Limited Liability), Fubon Bank (Hong Kong) Limited, Siemens Bank Gmbh Singapore Branch and the Bank of East Asia, Limited as Lead Arrangers Crédit Industriel Et Commercial, Hong Kong Branch (Incorporated in France With Limited Liability) as Arranger the Hongkong and Shanghai Banking Corporation Limited as Agent and the Hongkong and Shanghai Banking Corporation Limited as Security Agent Facilities Agreement

from 10-K 4 pages Certain Information (Indicated by “[…***…]”) Has Been Excluded From This Exhibit Because Such Information (I) Is Not Material and (II) Is the Type That the Company Treats as Private or Confidential. Fourth Amendment to Collaboration Agreement

from 10-K 4 pages Certain Information (Indicated by “[…***…]”) Has Been Excluded From This Exhibit Because Such Information (I) Is Not Material and (II) Is the Type That the Company Treats as Private or Confidential. Third Amendment to Collaboration Agreement

from 10-K 2 pages Certain Information (Indicated by “[…***…]”) Has Been Excluded From This Exhibit Because Such Information (I) Is Not Material and (II) Is the Type That the Company Treats as Private or Confidential

from 10-Q 4 pages Certain Information (Indicated by “[…***…]”) Has Been Excluded From This Exhibit Because Such Information (I) Is Not Material and (II) Is the Type That the Company Treats as Private or Confidential

from 10-Q 56 pages Certain Information (Indicated by “[…***…]”) Has Been Excluded From This Exhibit Because Such Information (I) Is Not Material and (II) Is the Type That the Company Treats as Private or Confidential. Royalty Purchase Agreement by and Between Beone Medicines I Gmbh, as the Seller, and Solely for Purposes of Article 4 and Section 10.13, BeOne Medicines Ltd., as the Seller Parent, on the One Hand and Royalty Pharma Investments 2023 Icav, as the Buyer, on the Other Hand Dated as of August 25, 2025

from 10-Q 3 pages May 9, 2025 Re: Sales Force Fte Invoicing Methodology

from 10-Q 8 pages BeOne Medicines Ltd. Fifth Amended and Restated 2018 Employee Share Purchase Plan

from 8-K12G3 15 pages Consulting Agreement

from 8-K12G3 9 pages Indemnification Agreement

from 8-K12G3 19 pages Executive Employment Agreement

from 8-K12G3 19 pages Executive Employment Agreement

from 8-K12G3 19 pages Executive Employment Agreement

from 8-K12G3 20 pages Executive Employment Agreement

from 8-K12G3 24 pages Executive Employment Agreement

from POS AM 3 pages Beone Medicines Ltd. Independent Non-Executive Director Compensation Policy

from 10-K 3 pages Second Amendment to the Settlement and Termination Agreement

from 8-K 28 pages Facility Agreement